v4tfkhf6 | Knowledge4COVID-19

Property	Value
?:creator	<https://research.tib.eu/covid-19/entity/Jim%C3%A9nez-Br%C3%ADtez%2C_Gustavo%3B_Ruiz%2C_Pablo%3B_Soler%2C_Xavier>
?:doi	10.1016/j.medcli.2020.07.001
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.medcli.2020.07.001>
?:journal	Med_Clin_(Barc)
?:license	els-covid
?:pdf_json_files	document_parses/pdf_json/9a7e58164cf8e033005b26a22c6b0e27aa6171b7.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7346781>
?:pmid	<https://research.tib.eu/covid-19/entity/32718713.0>
?:pmid	32718713.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/9a7e58164cf8e033005b26a22c6b0e27aa6171b7>
?:source	Elsevier; Medline; PMC
?:title	Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-07-09

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/v4tfkhf6>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/v4tfkhf6>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all